In Allergic conditions Nasorest 8mg Capsule provides relief from symptoms such as blocked or runny nose, sneezing, and itchy or watery eyes. This will make it easier for you to go about your daily activities. It can also give relief from allergic reactions after insect bites and symptoms of hives and eczema such as rash, swelling, itching, and irritation. This will improve the appearance of your skin and you may find that your mood and self-confidence improve as well. It rarely has any serious side effects and you may only need to take it on days you have symptoms. Moreover, Nasorest 8mg Capsule may make you feel less sleepy as compared to other antihistamine medicines. If you are taking it to prevent getting symptoms you should use it regularly to get the most benefit.
Nasorest 8mg Capsule may cause excessive drowsiness with alcohol.
Nasorest 8mg Capsule is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Nasorest 8mg Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Larger doses or prolonged use of Nasorest 8mg Capsule may cause sleepiness and other effects in the baby
Nasorest 8mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Nasorest 8mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Nasorest 8mg Capsule may be needed. Please consult your doctor.
There is limited information available on the use of Nasorest 8mg Capsule in patients with liver disease. Please consult your doctor.
If you miss a dose of Nasorest 8mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More